Comparative analysis of two coxsackievirus B3 strains: Putative influence of virus-receptor interactions on pathogenesis

Journal of Medical Virology

Volumn 67, Issue 2, 2002, Pages 224-233

  Selinka, H C ^a   Wolde, A ^a   Pasch, A ^b   Klingel, K ^b   Schnorr, J J ^c   Kpper, J H ^c   Lindberg, A M ^b   Kandolf, R ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Coxsackievirus B3; Myocarditis; Pancreatitis; Pathogenesis; Virus host cell interactions

Indexed keywords

DECAY ACCELERATING FACTOR; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; COXSACKIE VIRUS B3; CYTOPATHOGENIC EFFECT; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INOTROPISM; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; RECEPTOR BINDING; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD55; CHO CELLS; CRICETINAE; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; MICE; MYOCARDITIS; PANCREATITIS; RECEPTORS, VIRUS; TRANSFECTION;

ADENOVIRIDAE; COXSACKIEVIRUS; CRICETINAE;

EID: 0036256461     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2211     Document Type: Article

References (33)

1. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
2. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses
3. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
4. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors
5. Limited proteolysis of the coxsackievirus and adenovirus receptor (CAR) on HeLa cells exposed to trypsin
6. Purification of the putative coxsackievirus B receptor from HeLa cells
7. Characterization of the echovirus 7 receptor: Domains of CD55 critical for virus binding
8. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Localization to the 5′ nontranslated region
9. Coxsackievirus B3 clinical isolates and murine myocarditis
10. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain
11. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses
12. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells
13. Mechanisms and consequences of enterovirus persistence in cardiac myocytes an cells of the immune system
14. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation
15. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: Identification of target cells and cytopathic effects
16. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-strand RNA synthesis
17. Amplification and cloning of complete enterovirus genomes by long distance PCR
18. Viral infection and the pathogenesis of dilated cardiomyopathy
19. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor
20. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and swine vesicular disease virus
21. Evolving concepts of cause, consequence, and control in myocarditis
22. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3
23. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): Evidence for a secondary cellular factor in A-particle formation
24. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells
25. Attachment of coxsackievirus B3 variants to cell lines: Mapping of phenotypic differences to capsid protein VP1
26. Viral cell entry induced by crosslinked decay-accelerating factor
27. Coxsackieviruses B1, B3, and B5 use decay-accelerating factor as a receptor for cell attachment
28. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells
29. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule-1 for cell entry
30. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF
31. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
32. Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice
33. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection